UK markets closed

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0800+0.0200 (+1.89%)
At close: 04:00PM EDT
1.0900 +0.01 (+0.93%)
After hours: 07:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 64.90M
Enterprise value -59.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.30
Price/book (mrq)0.47
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.81

Trading information

Stock price history

Beta (5Y monthly) 1.77
52-week change 3-30.77%
S&P500 52-week change 323.76%
52-week high 32.2900
52-week low 30.6900
50-day moving average 30.9907
200-day moving average 31.1128

Share statistics

Avg vol (3-month) 3489.5k
Avg vol (10-day) 31.01M
Shares outstanding 560.09M
Implied shares outstanding 660.09M
Float 844.64M
% held by insiders 125.17%
% held by institutions 136.26%
Shares short (15 May 2024) 4714.07k
Short ratio (15 May 2024) 41.3
Short % of float (15 May 2024) 41.57%
Short % of shares outstanding (15 May 2024) 41.19%
Shares short (prior month 15 Apr 2024) 4662.73k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-762.22%

Management effectiveness

Return on assets (ttm)-28.58%
Return on equity (ttm)-64.20%

Income statement

Revenue (ttm)7.59M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)106.40%
Gross profit (ttm)N/A
EBITDA -105.89M
Net income avi to common (ttm)-116.39M
Diluted EPS (ttm)-1.9900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)151.98M
Total cash per share (mrq)2.53
Total debt (mrq)27.47M
Total debt/equity (mrq)20.06%
Current ratio (mrq)8.32
Book value per share (mrq)2.28

Cash flow statement

Operating cash flow (ttm)-96.53M
Levered free cash flow (ttm)-46.76M